GL1X · GenesisL1 explorer

Research workbench

Receptor for advanced glycation end products VC1 domain in complex with fragment 11

Analyse Receptor for advanced glycation end products VC1 domain in complex with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6XQ6
Type
protein
Length
405 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
Q15109
Ligands
V6P, CL

Structure

x-ray diffraction · 2 distinct chains.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein204—Q15109
B—protein201—Q15109

Ligands and binding sites

  • V6P · 3-phenoxyphenol · ligand · 3 copies · chains A, B
  • CL · Chloride ion · ion · 2 copies · chains A, B
  • ACT · Acetate ion · additive · 7 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 6XQ6 · Receptor for Advanced Glycation End Products VC1 domain in complex with Fragment 11 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q15109 · AlphaFold monomer V2.0 prediction for advanced glycosylation end product-specific… · a predicted model of the same protein · chain B against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.